The Asia Pacific dental bone graft substitute and barrier membrane market is expected to grow from US$ 99.42 million in 2022 to US$ 207.68 million by 2030. It is estimated to grow at a CAGR of 9.6% from 2022 to 2030.
Based on product, the Asia Pacific dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on country, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd and Institut Straumann AG in are some the leading companies operating in the Asia Pacific dental bone graft substitute and barrier membrane market.
Reasons to Buy
Digitization of Dentistry with CAD/CAM Technology Fuel Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market
Computer-aided design (CAD) and computer-aided manufacturing (CAM) software help dentists perform complex procedures at an accelerated pace, with greater accuracy, and lesser efforts. The benefits of CAD/CAM systems include user-friendly operations, digital impressions, single-visit treatments, improved patient safety, and long-lasting restorations. Moreover, digital dentistry with the integration of CAD/CAM enhances the productivity and profitability of a dental practice. The digitalization of dentistry with advancements in relevant technologies has enabled physicians to improve patient care by significantly reducing the time required for the restorative phase of treatment. CAD software also facilitates the digital designing of dental appliances, and CAM software aids in the manufacturing of the designed products. The accuracy and dependability of modern manufacturing processes, and 3D scanning have further led to more reliable manufacturing of dental objects. The CAD/CAM technology can be used for the milling of customized block grafts of xenogeneic, allogeneic, and alloplastic origins. The technology also enables the customized production of allogeneic bone blocks for complex ridge augmentation procedures. Thus, the use of CAD/CAM technology in dentistry is emerging as a notable trend in the Asia Pacific dental bone graft substitute and barrier membrane market .Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Overview
The Asia Pacific Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region during the forecast period. The market in Asia Pacific is expected to grow at a faster pace owing to factors such as high prevalence of dental problems, increased healthcare expenditure, and rise in the aging population. Moreover, increase in government initiatives, surge in oral health awareness and technological advancements, and an increasing focus of market players in emerging economies for developing dental practices are expected to boost the growth of the Asia Pacific Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market during the forecast period.Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The Asia Pacific dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.Based on product, the Asia Pacific dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Based on country, the Asia Pacific dental bone graft substitute and barrier membrane market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd and Institut Straumann AG in are some the leading companies operating in the Asia Pacific dental bone graft substitute and barrier membrane market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific dental bone graft substitute and barrier membrane market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific dental bone graft substitute and barrier membrane market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Landscape
5. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Key Industry Dynamics
6. Dental Bone Graft Substitute and Barrier Membrane Market - Asia Pacific Market Analysis
7. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Product
8. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Procedures
9. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by End User
10. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market - Country Analysis
11. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape
12. Asia Pacific Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Geistlich Pharma AG
- Medtronic Plc
- Dentsply Sirona Inc
- ZimVie Inc
- Regenity Biosciences Inc
- Neoss UK & Ireland Ltd
- Institut Straumann AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 106 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 99.42 Million |
| Forecasted Market Value by 2030 | 207.68 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Asia Pacific |
